Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by MRSPECon Oct 14, 2013 6:51pm

172 Views

Post# 21815243

RE:RE:RE:RE:I said it before

for me I have held on long enough, I am thinking US will give themselves an increase of credit from the make believe lenders and paint the picture that things are rosy again, making the markets happy. KNE if they cant release news this week, I will say the time for me was too long, im in at .105 was hoping for a 50% gain in 2 weeks when I bought many weeks back. The next week thing meant well see if news happens, a deal that will produce cash for kane

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December